Moderna (MRNA) Net Margin Growth (3y) (2020 - 2026)

Moderna (MRNA) Net Margin Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -374.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -44.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -759,845.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 7,793.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 82,312.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -5,319.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 9,934.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 31,387.00
10 Moderna 25.26 Bn 20.13 Bn 52.00 Mn -13,815.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -13,815.00
Mar 31, 2026 -34,949.00
Dec 31, 2025 -15,064.00
Sep 30, 2025 -5,069.00
Jun 30, 2025 -62,725.00
Mar 31, 2025 -95,936.00
Dec 31, 2024 -18,345.00
Sep 30, 2024 -6,638.00
Jun 30, 2024 -59,455.00
Mar 31, 2024 -76,663.00
Dec 31, 2023 5,553.00
Sep 30, 2023 -4,984.00
Jun 30, 2023 -22,654.00
Mar 31, 2023 155,424.00
Dec 31, 2022 90,477.00
Sep 30, 2022 75,372.00
Jun 30, 2022 107,855.00
Mar 31, 2022 88,810.00
Dec 31, 2021 47,433.00
Sep 30, 2021 27,739.00